Drugs / LY2922470
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01867216 | Jun 2013 → Jan 2014 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 1 | NCT01746017 | Dec 2012 → Mar 2013 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY2922470 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01746017 ↗ |
| Route | Oral | “Administered orally as capsules” NCT01746017 ↗ |